News
STAT+: Gilead foresees more growth in its HIV drugs
Gilead’s CEO believes the foundation of the company will continue to be its HIV franchise, particularly PrEP. #STATBreakthrough […]
HIV
News
STAT+: A battle between Gilead and the U.S. government over patents on HIV prevention pills goes to trial
The federal government and Gilead Sciences will square off in a Delaware courtroom this week in a bid to settle dueling claims over patent rights to HIV drugs Truvada and… […]
News
STAT+: Gilead wins a key battle with the CDC over patents for its Truvada HIV pill
The judge noted the CDC did not alert Gilead to a patent on Truvada until 2016, one year after it had been issued. […]
